Methadone May Treat Resistant Leukemia

Researchers in Germany have discovered that methadone, an agent used to break addiction to opioid drugs, has surprising killing power against leukemia cells, including treatment resistant forms of the cancer. Their laboratory study, published in the Aug. 1 issue of Cancer Research, a journal of the American Association for Cancer Research, suggests that methadone holds promise as a new therapy for leukemia, especially in patients whose cancer no longer responds to chemotherapy and radiation.

"Methadone kills sensitive leukemia cells and also breaks treatment resistance, but without any toxic effects on non-leukemic blood cells," said the study's senior author, Claudia Friesen, Ph.D., of the Institute of Legal Medicine at the University Ulm. "We find this very exciting, because once conventional treatments have failed a patient, which occurs in old and also in young patients, they have no other options."

Methadone, developed in Germany in the 1930s, is a low cost agent that acts on opioid receptors, and thus is used as an opioid substitute to treat addiction. Scientists have found that opioid receptors also exist on the surface of some cancer cells for reasons that are not understood. One research group tested the agent in human lung cancer cell lines and found that it can induce cell death.

In this study, Friesen and her colleagues tested methadone in leukemia cells in laboratory culture because this cancer also expresses the opioid receptor. Theirs is the first study to look at use of the agent in leukemia, specifically in lymphoblastic leukemia T-cell lines and human myeloid leukemia cell lines. They found that methadone was as effective as standard chemotherapies and radiation treatments against non-resistant leukemia cells, and that non-leukemic peripheral blood lymphocytes survived after methadone treatment.

To their surprise, they found that methadone also effectively killed leukemia that was resistant to multiple chemotherapies and to radiation. Probing the mechanism of methadone's action, the researchers found that it activates the mitochondrial pathway within leukemia cells, which activates enzymes called caspases that prompt a cell into apoptosis, also known as programmed cell death. Chemotherapy drugs use the same approach, but methadone activated caspases in sensitive leukemia cells, and also reversed deficient activation of caspases in resistant leukemia cells.

Friesen said the research team is beginning to study methadone treatment in animal models of human leukemia, and she also says that other cancers might be suitable for treatment with the agent.

Good medical advice and research is always great to hear. At ASH, all members/researchers share their information. We also share our testimonials about our individual success with the ASH products such as:

Rick L. - Illinois
My wife and I have experienced wonderful results of this product in the cleaning of our GI tracts, helping the body to rid illness and heal. I was diagnosed with MS in 2000 and prescribed several self injecting medicines and also chemotherapy. Long story short, after getting on the ASH products, I feel healthier, stronger and getting my life back.

Now I would like to share something else. A couple of months ago, I join a marketing company called, It's Good Business. The name really says it all. There is a good way to market and we found it, we use it and we share it. We work as a group. We invite others to join and offer them training. It's Good Business has the unique approach of buying customers and growing your business through a large retail customer base. Talk about the perfect home based business!

That's correct, we purchase our customers. Need more money? Buy more customers. Believe me, I don't miss dealing with leads! This makes so much more sense. Why don't you join us? It's simple, just register at: http://itsgoodbusiness.net to attend a presentation. The informative presentations are held every Sat at 1:00PM and every Wed at 7:00PM Pacific time. Just listen, then the decision is yours...

It's Good Business!

Jackie Whalen